A randomised double-blind , placebo-controlled , @-week three centre trial of memantine ( @mg/day ) was conducted in which tests of attention ( simple and choice reaction time ) and word recognition ( immediate and delayed ) from the CDR System were administered prior to dosing and again at @ and @weeks .